Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 369

1.

Methods and Challenges for Computational Data Analysis for DNA Adductomics.

Walmsley SJ, Guo J, Wang J, Villalta PW, Turesky RJ.

Chem Res Toxicol. 2019 Sep 24. doi: 10.1021/acs.chemrestox.9b00196. [Epub ahead of print]

PMID:
31549505
2.

Scientific Business Abstracts of the 113th Annual Meeting of the Association of Physicians of Great Britain and Ireland.

Cacciottolo TM, Perikari A, van der Klaauw A, Henning E, Stadler LKJ, Keogh J, Farooqi IS, Tenin G, Keavney B, Ryan E, Budd R, Bewley M, Coelho P, Rumsey W, Sanchez Y, McCafferty J, Dockrell D, Walmsley S, Whyte M, Liu Y, Choy MK, Tenin G, Abraham S, Black G, Keavney B, Ford T, Stanley B, Good R, Rocchiccioli P, McEntegart M, Watkins S, Eteiba H, Shaukat A, Lindsay M, Robertson K, Hood S, McGeoch R, McDade R, Sidik N, McCartney P, Corcoran D, Collison D, Rush C, McConnachie A, Touyz R, Oldroyd K, Berry C, Gazdagh G, Diver L, Marshall J, McGowan R, Ahmed F; DDD Study, Tobias E, Curtis E, Parsons C, Maslin K, D'Angelo S, Moon R, Crozier S, Gossiel F, Bishop N, Kennedy S, Papageorghiou A, Fraser R, Gandhi S, Prentice A, Inskip H, Godfrey K, Schoenmakers I, Javaid MK, Eastell R, Cooper C, Harvey N, Watt ER, Howden A, Mirchandani A, Coelho P, Hukelmann JL, Sadiku P, Plant TM, Cantrell DA, Whyte MKB, Walmsley SR, Mordi I, Forteath C, Wong A, Mohan M, Palmer C, Doney A, Rena G, Lang C, Gray EH, Azarian S, Riva A, Edwards H, McPhail MJW, Williams R, Chokshi S, Patel VC, Edwards LA, Page D, Miossec M, Williams S, Monaghan R, Fotiou E; CHANGE Study Collaborators, CheartED Study Collaborators, Santibanez-Koref M, Keavney B, Badat M, Mettananda S, Hua P, Schwessinger R, Hughes J, Higgs D, Davies J.

QJM. 2019 Sep 1;112(9):724-729. doi: 10.1093/qjmed/hcz175. No abstract available.

PMID:
31505685
3.

Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake among People Living with HIV.

Saeed S, Strumpf E, Moodie EEM, Wong L, Cox J, Walmsley S, Tyndall M, Cooper C, Conway B, Hull M, Martel-Laferriere V, Gill J, Wong A, Vachon ML, Klein MB; Canadian Co-Infection Cohort Study Investigators.

Clin Infect Dis. 2019 Aug 28. pii: ciz833. doi: 10.1093/cid/ciz833. [Epub ahead of print]

PMID:
31504327
4.

Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial.

Tan DHS, Rolon MJ, Figueroa MI, Sued O, Gun A, Kaul R, Raboud JM, Szadkowski L, Hull MW, Walmsley SL, Cahn P; Argentinean GARDEL research network.

PLoS One. 2019 Sep 6;14(9):e0221653. doi: 10.1371/journal.pone.0221653. eCollection 2019.

5.

Pressure regulates immune-cell function.

Walmsley SR.

Nature. 2019 Sep;573(7772):41-42. doi: 10.1038/d41586-019-02339-4. No abstract available.

PMID:
31481766
6.

Current Challenges and Solutions in Research and Clinical Care of Older Persons Living with HIV: Findings Presented at the 9th International Workshop on HIV and Aging.

Sundermann EE, Erlandson KM, Pope CN, Rubtsova A, Montoya J, Moore AA, Marzolini C, O'Brien KK, Pahwa S, Payne BAI, Rubin LH, Walmsley S, Haughey NJ, Montano M, Karris MY, Margolick JB, Moore DJ.

AIDS Res Hum Retroviruses. 2019 Sep 10. doi: 10.1089/AID.2019.0100. [Epub ahead of print]

PMID:
31373216
7.

Drug interactions are not always predictable: the curious case of valproic acid and dolutegravir and a possible explanation.

Tseng AL, Wong AYJ, McLelland CJ, Walmsley SL.

AIDS. 2019 Aug 1;33(10):1677-1679. doi: 10.1097/QAD.0000000000002256. No abstract available.

PMID:
31305336
8.

Truncated rank correlation (TRC) as a robust measure of test-retest reliability in mass spectrometry data.

Lim J, Yu D, Kuo HC, Choi H, Walmsley S.

Stat Appl Genet Mol Biol. 2019 May 30;18(4). pii: /j/sagmb.2019.18.issue-4/sagmb-2018-0056/sagmb-2018-0056.xml. doi: 10.1515/sagmb-2018-0056.

PMID:
31145698
9.

Heart Failure With Preserved Ejection Fraction in Women Living With HIV: Another Inflammatory Comorbidity?

Moayedi Y, Walmsley SL.

J Infect Dis. 2019 Apr 22. pii: jiz185. doi: 10.1093/infdis/jiz185. [Epub ahead of print] No abstract available.

PMID:
31100123
10.

Health professional views on the assessment and management of foot problems in people with psoriatic arthritis in Australia and New Zealand: a qualitative investigation.

Carter K, Walmsley S, Rome K, Turner DE.

BMC Musculoskelet Disord. 2019 May 4;20(1):191. doi: 10.1186/s12891-019-2572-6.

11.

Lymphocytic colitis in an HIV positive patient: is dolutegravir the cause?

Mclelland CJ, Tseng AL, Walmsley SL, Chakrabarti S.

AIDS. 2019 Jun 1;33(7):1265-1266. doi: 10.1097/QAD.0000000000002203. No abstract available.

PMID:
31045946
12.

Trends in cause-specific mortality in HIV-hepatitis C coinfection following hepatitis C treatment scale-up.

Kronfli N, Bhatnagar SR, Hull MW, Moodie EEM, Cox J, Walmsley S, Gill J, Cooper C, Martel-Laferrière V, Pick N, Klein MB; Canadian Co-Infection Cohort Investigators.

AIDS. 2019 May 1;33(6):1013-1022. doi: 10.1097/QAD.0000000000002156.

13.

Direct-Acting Antiviral Treatment Failure Among Hepatitis C and HIV-Coinfected Patients in Clinical Care.

Rossi C, Young J, Martel-Laferrière V, Walmsley S, Cooper C, Wong A, Gill MJ, Klein MB; Canadian Co-Infection Cohort Investigators .

Open Forum Infect Dis. 2019 Feb 13;6(3):ofz055. doi: 10.1093/ofid/ofz055. eCollection 2019 Mar.

14.

Tenofovir and emtricitabine resistance among antiretroviral-naive patients in the Canadian Observational Cohort Collaboration: implications for PrEP.

Younger J, Raboud J, Szadkowski L, Harrigan R, Walmsley S, Bayoumi AM, Klein MB, Cooper C, Burchell AN, Loutfy M, Hull M, Wong A, Thomas R, Hogg R, Montaner J, Tsoukas C, Antoniou T; Canadian Observational Cohort Collaboration.

Antivir Ther. 2019;24(3):211-220. doi: 10.3851/IMP3302.

PMID:
30873953
15.

Hypoxia and the regulation of myeloid cell metabolic imprinting: consequences for the inflammatory response.

Sadiku P, Walmsley SR.

EMBO Rep. 2019 May;20(5). pii: e47388. doi: 10.15252/embr.201847388. Epub 2019 Mar 14. Review.

16.

IL4Rα Signaling Abrogates Hypoxic Neutrophil Survival and Limits Acute Lung Injury Responses In Vivo.

Harris AJ, Mirchandani AS, Lynch RW, Murphy F, Delaney L, Small D, Coelho P, Watts ER, Sadiku P, Griffith D, Dickinson RS, Clark E, Willson JA, Morrison T, Mazzone M, Carmeliet P, Ghesquiere B, O'Kane C, McAuley D, Jenkins SJ, Whyte MKB, Walmsley SR.

Am J Respir Crit Care Med. 2019 Jul 15;200(2):235-246. doi: 10.1164/rccm.201808-1599OC.

17.

Perspectives of patients and health professionals on the experience of living with psoriatic arthritis-related foot problems: a qualitative investigation.

Carter K, Walmsley S, Chessman D, Rome K, Turner DE.

Clin Rheumatol. 2019 Jun;38(6):1605-1613. doi: 10.1007/s10067-018-04411-2. Epub 2019 Jan 8.

PMID:
30617439
18.

Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals.

Nitulescu R, Young J, Saeed S, Cooper C, Cox J, Martel-Laferriere V, Hull M, Walmsley S, Tyndall M, Wong A, Klein MB; Canadian Co-Infection Cohort Study.

Int J Drug Policy. 2019 Mar;65:41-49. doi: 10.1016/j.drugpo.2018.08.012. Epub 2018 Dec 26.

PMID:
30594080
19.

Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada.

Kronfli N, Nitulescu R, Cox J, Moodie EE, Wong A, Cooper C, Gill J, Walmsley S, Martel-Laferrière V, Hull MW, Klein MB; Canadian Co-Infection Cohort Study.

J Int AIDS Soc. 2018 Nov;21(11):e25197. doi: 10.1002/jia2.25197.

20.

Inflammation and Hypoxia: HIF and PHD Isoform Selectivity.

Watts ER, Walmsley SR.

Trends Mol Med. 2019 Jan;25(1):33-46. doi: 10.1016/j.molmed.2018.10.006. Epub 2018 Nov 12. Review.

21.

Successful use of the potent enzyme inducer enzalutamide in a treatment-experienced HIV-positive male with prostate cancer.

Nhean S, Bravo J, Sheehan NL, Walmsley S, Tilley D, Tseng AL.

AIDS. 2018 Nov 13;32(17):2640-2642. doi: 10.1097/QAD.0000000000002019. No abstract available.

PMID:
30379691
22.

Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial.

Tan DHS, Raboud JM, Szadkowski L, Grinsztejn B, Madruga JV, Figueroa MI, Cahn P, Barton SE, Clarke A, Fox J, Zubyk W, Walmsley SL; VALIDATE Study Group .

J Antimicrob Chemother. 2019 Feb 1;74(2):480-488. doi: 10.1093/jac/dky433.

23.

Loneliness and perceived social support in pregnancy and early postpartum of mothers living with HIV in Ontario, Canada.

Khan S, Ion A, Alyass A, Greene S, Kwaramba G, Smith S, Carvalhal A, Kennedy VL, Walmsley S, Loutfy M for the HIV Mothering Study Team.

AIDS Care. 2019 Mar;31(3):318-325. doi: 10.1080/09540121.2018.1515469. Epub 2018 Aug 29.

PMID:
30157684
24.

Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV/Hepatitis C co-infected individuals.

Saeed S, Moodie EEM, Strumpf E, Gill J, Wong A, Cooper C, Walmsley S, Hull M, Martel-Laferriere V, Klein MB; Canadian Co-Infection Cohort Study Investigators.

J Viral Hepat. 2018 Dec;25(12):1507-1514. doi: 10.1111/jvh.12985. Epub 2018 Sep 27.

PMID:
30141236
25.

The role of neutrophils in cancer.

Grecian R, Whyte MKB, Walmsley SR.

Br Med Bull. 2018 Dec 1;128(1):5-14. doi: 10.1093/bmb/ldy029. Review.

26.

The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living With Human Immunodeficiency Virus.

McClymont E, Lee M, Raboud J, Coutlée F, Walmsley S, Lipsky N, Loutfy M, Trottier S, Smaill F, Klein MB, Harris M, Cohen J, Yudin MH, Wobeser W, Money D; CTN 236 HPV in HIV Study Team .

Clin Infect Dis. 2019 Feb 15;68(5):788-794. doi: 10.1093/cid/ciy575.

PMID:
29985988
27.

Viral suppression and viral rebound among young adults living with HIV in Canada.

Palmer A, Gabler K, Rachlis B, Ding E, Chia J, Bacani N, Bayoumi AM, Closson K, Klein M, Cooper C, Burchell A, Walmsley S, Kaida A, Hogg R; Canadian Observational Cohort (CANOC) Collaboration.

Medicine (Baltimore). 2018 Jun;97(22):e10562. doi: 10.1097/MD.0000000000010562.

28.

Getting DAMP(s) Wets the Whistle for Neutrophil Recruitment.

Watts ER, Walmsley SR.

Immunity. 2018 May 15;48(5):846-848. doi: 10.1016/j.immuni.2018.04.027.

29.

Medication nonadherence, multitablet regimens, and food insecurity are key experiences in the pathway to incomplete HIV suppression.

Almeida-Brasil CC, Moodie EEM, McLinden T, Hamelin AM, Walmsley SL, Rourke SB, Wong A, Klein MB, Cox J.

AIDS. 2018 Jun 19;32(10):1323-1332. doi: 10.1097/QAD.0000000000001822.

PMID:
29683846
30.

A prototypic small molecule database for bronchoalveolar lavage-based metabolomics.

Walmsley S, Cruickshank-Quinn C, Quinn K, Zhang X, Petrache I, Bowler RP, Reisdorph R, Reisdorph N.

Sci Data. 2018 Apr 17;5:180060. doi: 10.1038/sdata.2018.60.

31.

Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 Agonists.

Bewley MA, Budd RC, Ryan E, Cole J, Collini P, Marshall J, Kolsum U, Beech G, Emes RD, Tcherniaeva I, Berbers GAM, Walmsley SR, Donaldson G, Wedzicha JA, Kilty I, Rumsey W, Sanchez Y, Brightling CE, Donnelly LE, Barnes PJ, Singh D, Whyte MKB, Dockrell DH; COPDMAP.

Am J Respir Crit Care Med. 2018 Sep 15;198(6):739-750. doi: 10.1164/rccm.201705-0903OC.

32.

Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis.

McLinden T, Moodie EEM, Hamelin AM, Harper S, Rossi C, Walmsley SL, Rourke SB, Cooper C, Klein MB, Cox J.

Drug Alcohol Depend. 2018 Apr 1;185:374-380. doi: 10.1016/j.drugalcdep.2017.12.031. Epub 2018 Feb 20.

PMID:
29544189
33.

Pseudomonas expression of an oxygen sensing prolyl hydroxylase homologue regulates neutrophil host responses in vitro and in vivo.

Dickinson RS, Murphy F, Doherty C, Williams S, Mirchandani A, Willson J, Scotti JS, Preston G, Schofield CJ, Whyte MKB, Walmsley SR.

Wellcome Open Res. 2017 Oct 26;2:104. doi: 10.12688/wellcomeopenres.12871.1. eCollection 2017.

34.

Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients.

Rossi C, Saeed S, Cox J, Vachon ML, Martel-Laferrière V, Walmsley SL, Cooper C, Gill MJ, Hull M, Moodie EEM, Klein MB; Canadian Co-Infection Cohort Investigators.

AIDS. 2018 Mar 27;32(6):751-759. doi: 10.1097/QAD.0000000000001750.

35.

Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in Girls Living With HIV.

Brophy J, Bitnun A, Alimenti A, Lapointe N, Samson L, Read S, Karatzios C, Dobson S, Moses E, Blitz S, Lipsky NG, Ogilvie G, Walmsley S, Raboud J, Money D; HPV in HIV Study Group.

Pediatr Infect Dis J. 2018 Jun;37(6):595-597. doi: 10.1097/INF.0000000000001874.

PMID:
29278613
36.

Pathways From HIV-Related Stigma to Antiretroviral Therapy Measures in the HIV Care Cascade for Women Living With HIV in Canada.

Logie CH, Lacombe-Duncan A, Wang Y, Kaida A, Conway T, Webster K, de Pokomandy A, Loutfy MR, Anema A, Becker D, Brotto L, Carter A, Cardinal C, Colley G, Ding E, Duddy J, Gataric N, Hogg RS, Hosward T, Jabbari S, Jones E, Kestler M, Langlois A, Lima V, Lloyd-Smith E, Medjuck M, Miller C, Money D, Nicholson V, Ogilvie G, Patterson S, Pick N, Roth E, Salters K, Sanchez M, Sas J, Sereda P, Summers M, Tom C, Wang L, Webster K, Zhang W, Abdul-Noor R, Angel J, Barry F, Bauer G, Beaver K, Benoit A, Bertozzi B, Borton S, Bourque T, Brophy J, Burchell A, Carlson A, Cioppa L, Cohen J, Conway T, Cooper C, Cotnam J, Cousineau J, Fraleigh A, Gagnier B, Gasingirwa C, Greene S, Hart T, Islam S, Kaushic C, Kennedy L, Kerr D, Kiboyogo M, Kwaramba G, Leonard L, Lewis J, Logie C, Margolese S, Muchenje M, Ndungʼu M, OʼBrien K, Ouellette C, Powis J, Quan C, Raboud J, Rachlis A, Ralph E, Rourke S, Rueda S, Sandre R, Smaill F, Smith S, Tigere T, Tharao W, Walmsley S, Wobeser W, Yee J, Yudin M, Baril JG, Burke NB, Clément P, Dayle J, Dubuc D, Fernet M, Groleau D, Hot A, Klein M, Martin C, Massie L, Ménard B, OʼBrien N, Otis J, Peltier D, Pierre A, Proulx-Boucher K, Rouleau D, Savoie É, Tremblay C, Trottier B, Trottier S, Tsoukas C, Gahagan J, Hankins C, Masching R, Ogunnaike-Cooke S.

J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):144-153. doi: 10.1097/QAI.0000000000001589.

37.

Elevated Levels of Estradiol in Human Immunodeficiency Virus-Infected Pregnant Women on Protease Inhibitor-Based Regimens.

Balogun KA, Guzman Lenis MS, Papp E, Loutfy M, Yudin MH, MacGillivray J, Walmsley SL, Silverman M, Serghides L.

Clin Infect Dis. 2018 Jan 18;66(3):420-427. doi: 10.1093/cid/cix761.

38.

Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine.

Perciani CT, Jaoko W, Walmsley S, Farah B, Mahmud SM, Ostrowski M, Anzala O, Team KI, MacDonald KS.

BMJ Open. 2017 Sep 21;7(9):e017391. doi: 10.1136/bmjopen-2017-017391.

39.

The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol.

Durand M, Chartrand-Lefebvre C, Baril JG, Trottier S, Trottier B, Harris M, Walmsley S, Conway B, Wong A, Routy JP, Kovacs C, MacPherson PA, Monteith KM, Mansour S, Thanassoulis G, Abrahamowicz M, Zhu Z, Tsoukas C, Ancuta P, Bernard N, Tremblay CL; investigators of the Canadian HIV and Aging Cohort Study.

BMC Infect Dis. 2017 Sep 11;17(1):611. doi: 10.1186/s12879-017-2692-2.

40.

A cross-sectional population-based study of breast cancer screening among women with HIV in Ontario, Canada.

Kendall CE, Walmsley S, Lau C, Jembere N, Burchell AN, Loutfy M, Raboud J, Rosenes R, Rourke SB, Antoniou T.

CMAJ Open. 2017 Aug 30;5(3):E673-E681. doi: 10.9778/cmajo.20170038.

41.

Prolyl hydroxylase 2 inactivation enhances glycogen storage and promotes excessive neutrophilic responses.

Sadiku P, Willson JA, Dickinson RS, Murphy F, Harris AJ, Lewis A, Sammut D, Mirchandani AS, Ryan E, Watts ER, Thompson AAR, Marriott HM, Dockrell DH, Taylor CT, Schneider M, Maxwell PH, Chilvers ER, Mazzone M, Moral V, Pugh CW, Ratcliffe PJ, Schofield CJ, Ghesquiere B, Carmeliet P, Whyte MK, Walmsley SR.

J Clin Invest. 2017 Sep 1;127(9):3407-3420. doi: 10.1172/JCI90848. Epub 2017 Aug 14.

42.

Debiasing visual pilots' weather-related decision making.

Walmsley S, Gilbey A.

Appl Ergon. 2017 Nov;65:200-208. doi: 10.1016/j.apergo.2017.06.019. Epub 2017 Jul 5.

PMID:
28802440
43.

Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study.

Orrell C, Hagins DP, Belonosova E, Porteiro N, Walmsley S, Falcó V, Man CY, Aylott A, Buchanan AM, Wynne B, Vavro C, Aboud M, Smith KY; ARIA study team.

Lancet HIV. 2017 Dec;4(12):e536-e546. doi: 10.1016/S2352-3018(17)30095-4. Epub 2017 Jul 17. Erratum in: Lancet HIV. 2017 Dec;4(12 ):e535.

PMID:
28729158
44.

Injection Drug Use, Unemployment, and Severe Food Insecurity Among HIV-HCV Co-Infected Individuals: A Mediation Analysis.

McLinden T, Moodie EEM, Hamelin AM, Harper S, Walmsley SL, Paradis G, Aibibula W, Klein MB, Cox J.

AIDS Behav. 2017 Dec;21(12):3496-3505. doi: 10.1007/s10461-017-1850-2.

PMID:
28726043
45.

The Use of Multistate Models to Examine Associations of Stress and Adherence With Transitions Among HIV Care States Observed in a Clinical HIV Cohort.

Blitz S, Antoniou T, Burchell A, Walmsley S, Light L, Gardner S, Rourke S, Cooper C, Kendall C, Loutfy M, Rachlis A, Wobeser W, Benoit A, Raboud J.

J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):303-310. doi: 10.1097/QAI.0000000000001493.

PMID:
28700406
46.

High retention in HIV care at a tertiary care centre in Toronto, Canada.

Szadkowski L, Walmsley S, Burchell AN, Collins E, Rourke SB, Raboud J; OHTN Cohort Study Team.

AIDS Care. 2018 Feb;30(2):246-254. doi: 10.1080/09540121.2017.1349278. Epub 2017 Jul 5.

PMID:
28678619
47.

Performance of a High-Pressure Liquid Chromatography-Ion Mobility-Mass Spectrometry System for Metabolic Profiling.

Zhang X, Kew K, Reisdorph R, Sartain M, Powell R, Armstrong M, Quinn K, Cruickshank-Quinn C, Walmsley S, Bokatzian S, Darland E, Rain M, Imatani K, Reisdorph N.

Anal Chem. 2017 Jun 20;89(12):6384-6391. doi: 10.1021/acs.analchem.6b04628. Epub 2017 Jun 2.

PMID:
28528542
48.

Exploring the Factors Considered by People Living with HIV and Their Partners during Preconception.

Kennedy VL, Collins M, Yudin MH, Serghides L, Walmsley S, Angel JB, Ongoiba F, Powis J, Smaill F, Tharao W, Rachlis A, Silverman M, Sandre R, Regier DA, Loutfy M.

J Int Assoc Provid AIDS Care. 2017 May/Jun;16(3):239-246. doi: 10.1177/2325957416682089. Epub 2016 Dec 19.

PMID:
28485707
49.

A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection.

Moqueet N, Kanagaratham C, Gill MJ, Hull M, Walmsley S, Radzioch D, Saeed S, Platt RW, Klein MB; Canadian Co-infection Cohort Study (CTN 222).

PLoS One. 2017 May 3;12(5):e0176282. doi: 10.1371/journal.pone.0176282. eCollection 2017.

50.

Erratum to: Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial.

Siou K, Walmsley SL, Murphy KE, Raboud J, Loutfy M, Yudin MH, Silverman M, Ladhani NN, Papp E, Serghides L.

Pilot Feasibility Stud. 2017 Apr 28;3:21. doi: 10.1186/s40814-017-0135-x. eCollection 2017.

Supplemental Content

Loading ...
Support Center